Table 1.
Demographic and clinical characteristics of the Echo-SOL population (N=1,815).
| N | % | |
|---|---|---|
| Age (median, IQR) | 54 | 49–60 |
| Sex | ||
| Female | 1184 | 65% |
| Male | 631 | 35% |
| Field Center | ||
| Bronx | 549 | 30% |
| Miami | 500 | 28% |
| San Diego | 349 | 19% |
| Chicago | 417 | 23% |
| Ethnicity | ||
| Dominican | 326 | 18% |
| Central American | 176 | 10% |
| Cuban | 356 | 20% |
| Mexican | 456 | 25% |
| Puerto Rican | 347 | 19% |
| South American | 150 | 8% |
| Multiple or other | 4 | <1% |
| Acculturation | ||
| U.S.-born | 162 | 9% |
| Lived in U.S. for ≥10 years | 1291 | 71% |
| Lived in U.S. for <10 years | 359 | 20% |
| Body mass index (kg/m2) (median, IQR) | 29.4 | 26.3–33.5 |
| Systolic blood pressure (mm Hg) (median, IQR) | 135 | 123–148 |
| Diastolic blood pressure (mm Hg) (median, IQR) | 78 | 71–86 |
| Use of antihypertensive medications | 480 | 26% |
| History of hypertension | 860 | 47% |
| Diabetes diagnosis | ||
| Diagnosed diabetic before baseline | 336 | 19% |
| Undiagnosed diabetic | 161 | 9% |
| Non-diabetic | 1317 | 73% |
| Use of anti-diabetes medications | 290 | 16% |
| Smoking status | ||
| Never | 1068 | 59% |
| Former | 441 | 24% |
| Current | 304 | 17% |
| HDL-cholesterol (mg/dL) (median, IQR) | 49 | 42–58 |
| LDL-cholesterol (mg/dL) (median, IQR) | 127 | 104–151 |
| Use of lipid-lowering medications | 356 | 20% |
| Estimated glomerular filtration rate (mL/min/1.73 m2 of body-surface area) (median, IQR) | 96.8 | 84.5–107.2 |
| <60 | 69 | 4% |
| ≥60 | 1726 | 95% |
| History of coronary heart disease | 5 | <1% |
| History of stroke/transient ischemic attack | 9 | <1% |
| History of heart failure | 21 | 1% |
N and % presented unless otherwise indicated. IQR = interquartile range.
Missing data: acculturation, N=3; body mass index and diabetes, N=1; systolic blood pressure, N=21; diastolic blood pressure, N=22; use of medications, N=36; smoking and HDL cholesterol, N=2; LDL-cholesterol, N=26; eGFR, N=20.